294 related articles for article (PubMed ID: 27910217)
1. Disentangling estimands and the intention-to-treat principle.
Leuchs AK; Brandt A; Zinserling J; Benda N
Pharm Stat; 2017 Jan; 16(1):12-19. PubMed ID: 27910217
[TBL] [Abstract][Full Text] [Related]
2. Is Intention to Treat Still the Gold Standard or Should Health Technology Assessment Agencies Embrace a Broader Estimands Framework?: Insights and Perspectives From the National Institute for Health and Care Excellence and Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen on the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use E9 (R1) Addendum.
Morga A; Latimer NR; Scott M; Hawkins N; Schlichting M; Wang J
Value Health; 2023 Feb; 26(2):234-242. PubMed ID: 36150999
[TBL] [Abstract][Full Text] [Related]
3. Precise definitions of some terminology for longitudinal clinical trials: subjects, patient populations, analysis sets, intention to treat, and related terms.
Helms RW
Pharm Stat; 2016 Nov; 15(6):471-485. PubMed ID: 27620652
[TBL] [Abstract][Full Text] [Related]
4. Choosing Estimands in Clinical Trials: Putting the ICH E9(R1) Into Practice.
Ratitch B; Bell J; Mallinckrodt C; Bartlett JW; Goel N; Molenberghs G; O'Kelly M; Singh P; Lipkovich I
Ther Innov Regul Sci; 2020 Mar; 54(2):324-341. PubMed ID: 32072573
[TBL] [Abstract][Full Text] [Related]
5. A systematic review finds variable use of the intention-to-treat principle in musculoskeletal randomized controlled trials with missing data.
Joseph R; Sim J; Ogollah R; Lewis M
J Clin Epidemiol; 2015 Jan; 68(1):15-24. PubMed ID: 25304501
[TBL] [Abstract][Full Text] [Related]
6. The use of the intention-to-treat principle in nursing clinical trials.
Polit DF; Gillespie BM
Nurs Res; 2009; 58(6):391-9. PubMed ID: 19918150
[TBL] [Abstract][Full Text] [Related]
7. Inconsistent definitions for intention-to-treat in relation to missing outcome data: systematic review of the methods literature.
Alshurafa M; Briel M; Akl EA; Haines T; Moayyedi P; Gentles SJ; Rios L; Tran C; Bhatnagar N; Lamontagne F; Walter SD; Guyatt GH
PLoS One; 2012; 7(11):e49163. PubMed ID: 23166608
[TBL] [Abstract][Full Text] [Related]
8. Good intentions and ICH-GCP: Trial conduct training needs to go beyond the ICH-GCP document and include the intention-to-treat principle.
Browne LH; Graham PH
Clin Trials; 2014 Dec; 11(6):629-34. PubMed ID: 25023199
[TBL] [Abstract][Full Text] [Related]
9. Handling missing data in RCTs; a review of the top medical journals.
Bell ML; Fiero M; Horton NJ; Hsu CH
BMC Med Res Methodol; 2014 Nov; 14():118. PubMed ID: 25407057
[TBL] [Abstract][Full Text] [Related]
10. The intention-to-treat approach in randomized controlled trials: are authors saying what they do and doing what they say?
Gravel J; Opatrny L; Shapiro S
Clin Trials; 2007; 4(4):350-6. PubMed ID: 17848496
[TBL] [Abstract][Full Text] [Related]
11. Intention-to-treat and transparency of related practices in randomized, controlled trials of anti-infectives.
Beckett RD; Loeser KC; Bowman KR; Towne TG
BMC Med Res Methodol; 2016 Aug; 16(1):106. PubMed ID: 27557676
[TBL] [Abstract][Full Text] [Related]
12. Considerations for Evaluating Treatment Effects From Randomized Clinical Trials.
Ruberg SJ; Akacha M
Clin Pharmacol Ther; 2017 Dec; 102(6):917-923. PubMed ID: 28891044
[TBL] [Abstract][Full Text] [Related]
13. Clarifying selection bias in cluster randomized trials.
Li F; Tian Z; Bobb J; Papadogeorgou G; Li F
Clin Trials; 2022 Feb; 19(1):33-41. PubMed ID: 34894795
[TBL] [Abstract][Full Text] [Related]
14. Estimands: discussion points from the PSI estimands and sensitivity expert group.
Phillips A; Abellan-Andres J; Soren A; Bretz F; Fletcher C; France L; Garrett A; Harris R; Kjaer M; Keene O; Morgan D; O'Kelly M; Roger J
Pharm Stat; 2017 Jan; 16(1):6-11. PubMed ID: 26997517
[TBL] [Abstract][Full Text] [Related]
15. Estimands in clinical trials - broadening the perspective.
Akacha M; Bretz F; Ruberg S
Stat Med; 2017 Jan; 36(1):5-19. PubMed ID: 27435045
[TBL] [Abstract][Full Text] [Related]
16. Estimands: A More Strategic Approach to Study Design and Analysis.
Akacha M; Kothny W
Clin Pharmacol Ther; 2017 Dec; 102(6):894-896. PubMed ID: 29119556
[TBL] [Abstract][Full Text] [Related]
17. Addressing missing participant outcome data in dental clinical trials.
Spineli LM; Fleming PS; Pandis N
J Dent; 2015 Jun; 43(6):605-18. PubMed ID: 25837533
[TBL] [Abstract][Full Text] [Related]
18. Estimands for clinical endpoints in tuberculosis treatment randomized controlled trials: a retrospective application in a completed trial.
Weir IR; Dufault SM; Phillips PPJ
Trials; 2024 Mar; 25(1):180. PubMed ID: 38468320
[TBL] [Abstract][Full Text] [Related]
19. A framework for the design, conduct and interpretation of randomised controlled trials in the presence of treatment changes.
Dodd S; White IR; Williamson P
Trials; 2017 Oct; 18(1):498. PubMed ID: 29070048
[TBL] [Abstract][Full Text] [Related]
20. Estimating effects from randomized trials with discontinuations: the need for intent-to-treat design and G-estimation.
Greenland S; Lanes S; Jara M
Clin Trials; 2008; 5(1):5-13. PubMed ID: 18283074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
